^
Association details:
| Biomarker: | CCDC69 overexpression |
|---|---|
| Cancer: | Bladder Cancer |
| Drug Class: | Immunotherapy |
| Direction: | Sensitive |
Evidence:
Source:
Title:
High expression of CCDC69 is correlated with immunotherapy response and protective effects on breast cancer
Published date:
10/12/2023
Excerpt:
In the ICI-treated patient cohort of Camoip database, we found that higher expression level of CCDC69 could predict better immunotherapy benefits in bladder cancer, as shown by OS (HR = 0.76, 95%CI (0.58–0.98), p = 0.034)